Molecular, endocrine, and genetic mechanisms of arterial calcification
Pathologists have recognized arterial calcification for over a century. Recent years have
witnessed a strong resurgence of interest in atherosclerotic plaque calcification because it …
witnessed a strong resurgence of interest in atherosclerotic plaque calcification because it …
Core-binding factors in hematopoiesis and immune function
MFTR de Bruijn, NA Speck - Oncogene, 2004 - nature.com
Core binding factors are heterodimeric transcription factors containing a DNA binding
Runx1, Runx2, or Runx3 subunit, along with a non DNA binding CBFβ subunit. All four …
Runx1, Runx2, or Runx3 subunit, along with a non DNA binding CBFβ subunit. All four …
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
JD Growney, H Shigematsu, Z Li, BH Lee… - Blood, 2005 - ashpublications.org
Homozygous loss of function of Runx1 (Runt-related transcription factor 1 gene) during
murine development results in an embryonic lethal phenotype characterized by a complete …
murine development results in an embryonic lethal phenotype characterized by a complete …
RUNX1 and GATA-1 coexpression and cooperation in megakaryocytic differentiation
KE Elagib, FK Racke, M Mogass, R Khetawat… - blood, 2003 - ashpublications.org
Megakaryocytic and erythroid lineages derive from a common bipotential progenitor and
share many transcription factors, most prominently factors of the GATA zinc-finger family …
share many transcription factors, most prominently factors of the GATA zinc-finger family …
Cbfβ interacts with Runx2 and has a critical role in bone development
M Kundu, A Javed, JP Jeon, A Horner, L Shum… - Nature …, 2002 - nature.com
Runx2 (runt-related transcription factor 2, also known as Cbfa1, Osf2 and AML3) is essential
for bone development in mice, and mutations in RUNX2 are found in 65–80% of individuals …
for bone development in mice, and mutations in RUNX2 are found in 65–80% of individuals …
Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells
TE North, T Stacy, CJ Matheny, NA Speck… - Stem …, 2004 - academic.oup.com
The transcription factor Runx1 marks all functional hematopoietic stem cells (HSCs) in the
embryo and is required for their generation. Mutations in Runx1 are found in approximately …
embryo and is required for their generation. Mutations in Runx1 are found in approximately …
Dysregulation of the transcription factors SOX4, CBFB and SMARCC1 correlates with outcome of colorectal cancer
CL Andersen, LL Christensen, K Thorsen… - British journal of …, 2009 - nature.com
The aim of this study was to identify deregulated transcription factors (TFs) in colorectal
cancer (CRC) and to evaluate their relation with the recurrence of stage II CRC and overall …
cancer (CRC) and to evaluate their relation with the recurrence of stage II CRC and overall …
Role of RUNX1 in adult hematopoiesis: analysis of RUNX1-IRES-GFP knock-in mice reveals differential lineage expression
RB Lorsbach, J Moore, SO Ang, W Sun, N Lenny… - Blood, 2004 - ashpublications.org
The Runx1/core binding factor-β (CBFβ) transcriptional complex is required for the
establishment of hematopoiesis during development. Despite its critical role during …
establishment of hematopoiesis during development. Despite its critical role during …
KIT activating mutations: incidence in adult and pediatric acute myeloid leukemia, and identification of an internal tandem duplication
BACKGROUND AND OBJECTIVES: Mutations of KIT receptor tyrosine kinase are involved
in the constitutive activation and development of human hematologic malignancies. Gain-of …
in the constitutive activation and development of human hematologic malignancies. Gain-of …
Pathogenesis of acute myeloid leukaemia and inv (16)(p13; q22): a paradigm for understanding leukaemogenesis?
JT Reilly - British journal of haematology, 2005 - Wiley Online Library
Acute myeloid leukaemia (AML) has been proposed to arise from the collaboration between
two classes of mutation, a class I, or proliferative, mutation and a class II, or blocking …
two classes of mutation, a class I, or proliferative, mutation and a class II, or blocking …